NY Times highlights NC TraCS-supported Monitor trial

A UNC study supported by a wide variety of NC TraCS services and personnel received attention in a NY Times OpEd piece this week.

The Monitor trial, which took place in 15 primary care practices in North Carolina, found no measurable differences in how patients with type 2 diabetes fared, whether they checked blood sugar or not. Drs. Katrina Donahue and Laura Young oversaw the involvement of the practices in the trial, the latest to indicate that self-monitoring of blood sugar is unnecessary for a large proportion of diabetes patients.

Read more: A Diabetes Home Test Can Be a Waste of Time and Money (NY Times)

View news related to policies and regulations

Have news or an announcement to share? Contact Michelle Maclay at michelle_maclay@med.unc.edu

Get NC TraCS events and news delivered to your inbox! Subscribe to our weekly email blast

NC TraCS Institute logo vertical

In partnership with:

Contact Us


Brinkhous-Bullitt, 2nd floor
160 N. Medical Drive
Chapel Hill, NC 27599

919.966.6022
This email address is being protected from spambots. You need JavaScript enabled to view it.

Social


Cite Us


CitE and SUBMit CTSA Grant number - UM1TR004406

© 2008-2024 The North Carolina Translational and Clinical Sciences (NC TraCS) Institute at The University of North Carolina at Chapel Hill
The content of this website is solely the responsibility of the University of North Carolina at Chapel Hill and does not necessarily represent the official views of the NIH   accessibility | contact